The Cochaperone p23 Differentially Regulates Estrogen Receptor Target Genes and Promotes Tumor Cell Adhesion and Invasion
- 1 July 2006
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 26 (14) , 5205-5213
Abstract
The cochaperone p23 plays an important role in estrogen receptor alpha (ER) signal transduction. In this study, we investigated how p23 regulates ER target gene activation and affects tumor growth and progression. Remarkably, we found that changes in the expression of p23 differentially affected the activation of ER target genes in a manner dependent upon the type of DNA regulatory element. p23 overexpression enhanced the expression of the ER target genes cathepsin D and pS2, which are regulated by direct DNA binding of ER to estrogen response elements (ERE). In contrast, the expression of other target genes, including c-Myc, cyclin D1, and E2F1, to which ER is recruited indirectly through its interaction with other transcription factors remains unaffected by changes in p23 levels. The p23-induced expression of pS2 is associated with enhanced recruitment of ER to the ERE in the promoter, whereas ER recruitment to the ERE-less c-Myc promoter does not respond to p23. Intriguingly, p23-overexpressing MCF-7 cells exhibit increased adhesion and invasion in the presence of fibronectin. Our findings demonstrate that p23 differentially regulates ER target genes and is involved in the control of distinct cellular processes in breast tumor development, thus revealing novel functions of this cochaperone.Keywords
This publication has 37 references indexed in Scilit:
- The Co-chaperone p23 Arrests the Hsp90 ATPase Cycle to Trap Client ProteinsJournal of Molecular Biology, 2006
- Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasivenessNature Cell Biology, 2004
- Rapid Glucocorticoid Receptor Exchange at a Promoter Is Coupled to Transcription and Regulated by Chaperones and ProteasomesMolecular and Cellular Biology, 2004
- A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitorsNature, 2003
- Telomerase as a Target for Cancer ImmunotherapyCancer Biology & Therapy, 2003
- Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progressionEuropean Journal of Cancer, 2002
- Translocations involving c-myc and c-myc functionOncogene, 2001
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000
- The Hallmarks of CancerCell, 2000
- Clinical and biological significance of HSP89 alpha in human breast cancerInternational Journal of Cancer, 1992